Gyre Therapeutics, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.01x
Net debt / equity: -0.36x
Debt / assets: 0.01x
Debt / EBITDA: 0.26x
Net debt / EBITDA: -11.63x

Liquidity & coverage

Current ratio: 4.64x
Quick ratio: 4.06x
Cash ratio: 2.52x
Interest coverage: —
EBITDA / interest: —
Working capital: $71.9M

Cash & dividend

FCF / debt: 3.69x
Cash flow / debt: 5.25x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: -83.2%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.